Advertisement

CNS Drugs

, Volume 22, Issue 5, pp 389–406 | Cite as

Burden of Bipolar Depression

Impact of Disorder and Medications on Quality of Life
  • Erin E. MichalakEmail author
  • Greg Murray
  • Allan H. Young
  • Raymond W. Lam
Review Article

Abstract

Bipolar disorder is a complex, chronic psychiatric condition characterized by recurring episodes of depressive illness and mania or hypomania. Although the manic or hypomanic episodes define the disorder, recent research has shown that depressive symptoms predominate over manic symptoms in the majority of patients, and that bipolar depression accounts for much of the significant morbidity and mortality associated with bipolar disorder. Given these findings, there has been a recent upsurge of interest in furthering our understanding of the burden of depression in bipolar disorder. At the same time, increasing scientific attention is now being paid to expanding the measurement of outcome in bipolar disorder to encompass broader indicators of response, one of which is the assessment of quality of life (QOL).

In this review, we provide a summary of the current knowledge about QOL in the depressive phase of bipolar disorder, and the effects of pharmacological treatment interventions for bipolar disorder upon QOL. It appears that QOL is poorer in bipolar disorder than in other mood disorders and anxiety disorders, but that schizophrenia might compromise QOL more severely than bipolar disorder. Existing data also suggest that, for patients with bipolar disorder, QOL is negatively associated with depression, both as a cross-sectional mood state and perhaps also as a feature of the patient’s course. Despite its clinical and public health importance, bipolar depression has only recently started to receive the attention it warrants in clinical trials, and many important questions about its optimal pharmacological management remain to be answered. There is also a paucity of information about the impact of pharmacological interventions on QOL in bipolar depression. To our knowledge, only two clinical trials to date have specifically examined the impact of medications on QOL in patients with bipolar depression. A small number of other studies have examined the effects of depressive symptoms on QOL in patients who are experiencing manic or mixed episodes. Nonetheless, QOL appears to be a meaningful and important indicator of outcome and recovery in this patient population, and one that warrants further scientific interest and energy.

Keywords

Depressive Symptom Bipolar Disorder Bipolar Depression Unipolar Depression Young Mania Rate Scale 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

Erin Michalak is supported by a Michael Smith Scholar Award from the Michael Smith Foundation for Health Research and a Canadian Institutes of Health Research New Investigator Award.

Raymond Lam is a speaker, is on advisory boards or has received research funding from Advanced Neuromodulation Systems, Inc., AstraZeneca, Biovail, Canadian Institutes of Health Research, Canadian Network for Mood and Anxiety Treatments, Eli Lilly, GlaxoSmithKline, GreatWest Life, Janssen, Litebook Company Ltd, Lundbeck, Sanofi-Aventis, Servier, VGH and UBC Hospital Foundation, and Wyeth.

References

  1. 1.
    Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59(6): 530–7PubMedCrossRefGoogle Scholar
  2. 2.
    Judd LL, Schettler PJ, Akiskal HS, et al. Long-term symptomatic status of bipolar I vs. bipolar II disorders. Int J Neuropsychopharmacol 2003; 6(2): 127–37Google Scholar
  3. 3.
    Post RM, Nolen WA, Kupka RW, et al. The Stanley Foundation Bipolar Network: I. Rationale and methods. Br J Psychiatry 2001; 41 Suppl.: S169–76CrossRefGoogle Scholar
  4. 4.
    Leverich GS, Post RM. Life charting of affective disorders. CNS Spectrums 1998; 3: 21–37Google Scholar
  5. 5.
    Post RM, Leverich GS, Altshuler LL, et al. An overview of recent findings of the Stanley Foundation Bipolar Network (part I). Bipolar Disord 2003; 5(5): 310–9PubMedCrossRefGoogle Scholar
  6. 6.
    Altshuler LL, Post RM, Black DO, et al. Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study. J Clin Psychiatry 2006; 67(10): 1551–60PubMedCrossRefGoogle Scholar
  7. 7.
    Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors. Global Burden of Disease Study. Lancet 1997; 349(9063): 1436–42Google Scholar
  8. 8.
    US Department of Health, Education and Welfare. Medical practice project: a state of the service report for the office of the assistant secretary for the US Dept of Health, Education and Welfare [policy research]. Washington, DC: US Department of Health, Education and Welfare, 1979Google Scholar
  9. 9.
    Weissman MM, Bland RC, Canino GJ, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996; 276(4): 293–9PubMedCrossRefGoogle Scholar
  10. 10.
    Angst J, Cassano G. The mood spectrum: improving the diagnosis of bipolar disorder. Bipolar Disord 2005; 7Suppl. 4: 4–12PubMedCrossRefGoogle Scholar
  11. 11.
    Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 1998; 50(2–3): 143–51PubMedCrossRefGoogle Scholar
  12. 12.
    Wyatt RJ, Henter I. An economic evaluation of manic-depressive illness: 1991. Soc Psychiatry Psychiatr Epidemiol 1995; 30(5): 213–9PubMedGoogle Scholar
  13. 13.
    Suppes T, Kelly DI, Perla JM. Challenges in the management of bipolar depression. J Clin Psychiatry 2005; 66Suppl. 5: 11–6PubMedGoogle Scholar
  14. 14.
    Matza LS, Rajagopalan KS, Thompson CL, et al. Misdiagnosed patients with bipolar disorder: comorbidities, treatment patterns, and direct treatment costs. J Clin Psychiatry 2005; 66(11): 1432–40PubMedCrossRefGoogle Scholar
  15. 15.
    McCombs JS, Ahn J, Tencer T, et al. The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis. J Affect Disord 2007; 97(1–3): 171–9PubMedCrossRefGoogle Scholar
  16. 16.
    Hirschfeld RM, Vornik LA. Recognition and diagnosis of bipolar disorder. J Clin Psychiatry 2004; 65Suppl. 15: 5–9PubMedGoogle Scholar
  17. 17.
    Hankin BL, Fraley RC, Lahey BB, et al. Is depression best viewed as a continuum or discrete category? A taxometric analysis of childhood and adolescent depression in a population-based sample. J Abnorm Psychol 2005; 114(1): 96–110PubMedCrossRefGoogle Scholar
  18. 18.
    Cuellar AK, Johnson SL, Winters R. Distinctions between bipolar and unipolar depression. Clin Psychol Rev 2005; 25(3): 307–39PubMedCrossRefGoogle Scholar
  19. 19.
    Schweitzer I, Maguire K, Ng C. Should bipolar disorder be viewed as manic disorder? Implications for bipolar depression. Bipolar Disord 2005; 7(5): 418–23PubMedCrossRefGoogle Scholar
  20. 20.
    Murray G, Goldstone E, Cunningham E. Personality and the predisposition(s) to bipolar disorder: heuristic benefits of a two-dimensional model. Bipolar Disord 2007; 9(5): 453–61PubMedCrossRefGoogle Scholar
  21. 21.
    Michalak EE, Murray GW, Young AH, et al. Quality of life impairment in bipolar disorder. In: Ritsner MS, Awad AG, editors. Quality of life impairment in schizophrenia, mood and anxiety disorders: from brain functions to clinical practice. Dordrecht: Springer, 2007Google Scholar
  22. 22.
    Kurs R, Farkas H, Ritsner M. Quality of life and temperament factors in schizophrenia: comparative study of patients, their siblings and controls. Qual Life Res 2005; 14(2): 433–40PubMedCrossRefGoogle Scholar
  23. 23.
    Perlis RH, Ostacher MJ, Patel JK, et al. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2006; 163(2): 217–24PubMedCrossRefGoogle Scholar
  24. 24.
    Dilsaver SC, Chen YW, Swann AC, et al. Suicidality, panic disorder and psychosis in bipolar depression, depressive-mania and pure-mania. Psychiatry Res 1997; 73(1–2): 47–56PubMedCrossRefGoogle Scholar
  25. 25.
    Lam D, Wong G. Prodromes, coping strategies and psychological interventions in bipolar disorders. Clin Psychol Rev 2005; 25(8): 1028–42PubMedCrossRefGoogle Scholar
  26. 26.
    Keller MB, Lavori PW, Coryell W, et al. Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA 1986; 255(22): 3138–42PubMedCrossRefGoogle Scholar
  27. 27.
    Post RM, Denicoff KD, Leverich GS, et al. Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry 2003; 64(6): 680–90PubMedCrossRefGoogle Scholar
  28. 28.
    Altshuler LL, Gitlin MJ, Mintz J, et al. Subsyndromal depression is associated with functional impairment in patients with bipolar disorder. J Clin Psychiatry 2002; 63(9): 807–11PubMedCrossRefGoogle Scholar
  29. 29.
    Yatham LN, Lecrubier Y, Fieve RR, et al. Quality of life in patients with bipolar I depression: data from 920 patients. Bipolar Disord 2004; 6(5): 379–85PubMedCrossRefGoogle Scholar
  30. 30.
    Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992; 30(6): 473–83Google Scholar
  31. 31.
    Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psych 1967; 6: 278–96CrossRefGoogle Scholar
  32. 32.
    Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429–35PubMedCrossRefGoogle Scholar
  33. 33.
    Keck Jr PE. Defining and improving response to treatment in patients with bipolar disorder. J Clin Psychiatry 2004; 65Suppl. 15: 25–9PubMedGoogle Scholar
  34. 34.
    Colom F, Vieta E. A perspective on the use of psychoeducation, cognitive-behavioral therapy and interpersonal therapy for bipolar patients. Bipolar Disord 2004; 6(6): 480–6PubMedCrossRefGoogle Scholar
  35. 35.
    Harvey PD. Defining and achieving recovery from bipolar disorder. J Clin Psychiatry 2006; 67Suppl. 9: 14–8PubMedGoogle Scholar
  36. 36.
    Mintz J, Mintz LI, Arruda MJ, et al. Treatments of depression and the functional capacity to work. Arch Gen Psychiatry 1992; 49(10): 761–8PubMedCrossRefGoogle Scholar
  37. 37.
    Altshuler L, Mintz J, Leight K. The life functioning questionnaire (LFQ): a brief, gender-neutral scale assessing functional outcome. Psychiatry Res 2002; 112(2): 161–82PubMedCrossRefGoogle Scholar
  38. 38.
    Leon AC, Solomon DA, Mueller TI, et al. The range of impaired functioning tool (LIFE-RIFT): a brief measure of functional impairment. Psychol Med 1999; 29(4): 869–78PubMedCrossRefGoogle Scholar
  39. 39.
    Coons SJ, Rao S, Keininger DL, et al. A comparative review of generic quality-of-life instruments. Pharmacoeconomics 2000; 17(1): 13–35PubMedCrossRefGoogle Scholar
  40. 40.
    The WHOQOL Group. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995; 41(10): 1403–9CrossRefGoogle Scholar
  41. 41.
    Namjoshi MA, Buesching DP. A review of the health-related quality of life literature in bipolar disorder. Qual Life Res 2001; 10(2): 105–15PubMedCrossRefGoogle Scholar
  42. 42.
    Dean BB, Gerner D, Gerner RH. A systematic review evaluating health-related quality of life, work impairment, and healthcare costs and utilization in bipolar disorder. Curr Med Res Opin 2004; 20(2): 139–54PubMedCrossRefGoogle Scholar
  43. 43.
    Revicki DA, Matza LS, Flood E, et al. Bipolar disorder and health-related quality of life: review of burden of disease and clinical trials. Pharmacoeconomics 2005; 23(6): 583–94PubMedCrossRefGoogle Scholar
  44. 44.
    Michalak EE, Yatham LN, Lam RW. Quality of life in bipolar disorder: a review of the literature. Health Qual Life Outcomes 2005; 3: 72PubMedCrossRefGoogle Scholar
  45. 45.
    Russo J, Roy-Byrne P, Reeder D, et al. Longitudinal assessment of quality of life in acute psychiatric inpatients: reliability and validity. J Nerv Ment Dis 1997; 185(3): 166–75PubMedCrossRefGoogle Scholar
  46. 46.
    Zhang H, Wisniewski SR, Bauer MS, et al. Comparisons of perceived quality of life across clinical states in bipolar disorder: data from the first 2000 Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) participants. Compr Psychiatry 2006; 47(3): 161–8PubMedCrossRefGoogle Scholar
  47. 47.
    Sachs GS, Thase ME, Otto MW, et al. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry 2003; 53(11): 1028–42PubMedCrossRefGoogle Scholar
  48. 48.
    Endicott J, Nee J, Harrison W, et al. Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmacol Bull 1993; 29(2): 321–6PubMedGoogle Scholar
  49. 49.
    Arnold LM, Witzeman KA, Swank ML, et al. Health-related quality of life using the SF-36 in patients with bipolar disorder compared with patients with chronic back pain and the general population. J Affect Disord 2000; 57(1–3): 235–9PubMedCrossRefGoogle Scholar
  50. 50.
    ten Have M, Vollebergh W, Bijl R, et al. Bipolar disorder in the general population in The Netherlands (prevalence, consequences and care utilisation): results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). J Affect Disord 2002; 68(2–3): 203–13PubMedCrossRefGoogle Scholar
  51. 51.
    Lehman AF. A quality of life interview for the chronically mentally ill. Eval Program Plann 1988; 11: 51–62CrossRefGoogle Scholar
  52. 52.
    Berlim MT, Pargendler J, Caldieraro MA, et al. Quality of life in unipolar and bipolar depression: are there significant differences? J Nerv Ment Dis 2004; 192(11): 792–5PubMedCrossRefGoogle Scholar
  53. 53.
    The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 1998; 28(3): 551–8CrossRefGoogle Scholar
  54. 54.
    Kraepelin E. Manic-depressive insanity and paranoia. Edinburgh: E and S Livingstone, 1921Google Scholar
  55. 55.
    Morgan VA, Mitchell PB, Jablensky AV. The epidemiology of bipolar disorder: sociodemographic, disability and service utilization data from the Australian National Study of Low Prevalence (Psychotic) Disorders. Bipolar Disord 2005; 7(4): 326–37PubMedCrossRefGoogle Scholar
  56. 56.
    Krabbendam L, Arts B, van Os J, et al. Cognitive functioning in patients with schizophrenia and bipolar disorder: a quantitative review. Schizophr Res 2005; 80(2–3): 137–49PubMedCrossRefGoogle Scholar
  57. 57.
    Martinez-Aran A, Penades R, Vieta E, et al. Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcome. Psychother Psychosom 2002; 71(1): 39–46PubMedCrossRefGoogle Scholar
  58. 58.
    Chand PK, Mattoo SK, Sharan P. Quality of life and its correlates in patients with bipolar disorder stabilized on lithium prophylaxis. Psychiatry Clin Neurosci 2004; 58(3): 311–8PubMedCrossRefGoogle Scholar
  59. 59.
    Atkinson M, Zibin S, Chuang H. Characterizing quality of life among patients with chronic mental illness: a critical examination of the self-report methodology. Am J Psychiatry 1997; 154(1): 99–105PubMedGoogle Scholar
  60. 60.
    Ferrans CE, Powers MJ. Psychometric assessment of the Quality of Life Index. Res Nurs Health 1992; 15(1): 29–38PubMedCrossRefGoogle Scholar
  61. 61.
    Dell’Osso L, Pini S, Cassano GB, et al. Insight into illness in patients with mania, mixed mania, bipolar depression and major depression with psychotic features. Bipolar Disord 2002; 4(5): 315–22PubMedCrossRefGoogle Scholar
  62. 62.
    Ghaemi SN, Stoll AL, Pope Jr HG. Lack of insight in bipolar disorder: the acute manic episode. J Nerv Ment Dis 1995; 183(7): 464–7PubMedCrossRefGoogle Scholar
  63. 63.
    Goldberg JF, Harrow M. Subjective life satisfaction and objective functional outcome in bipolar and unipolar mood disorders: a longitudinal analysis. J Affect Disord 2005; 89(1–3): 79–89PubMedCrossRefGoogle Scholar
  64. 64.
    Leidy NK, Palmer C, Murray M, et al. Health-related quality of life assessment in euthymic and depressed patients with bipolar disorder: psychometric performance of four self-report measures. J Affect Disord 1998; 48(2–3): 207–14PubMedCrossRefGoogle Scholar
  65. 65.
    Ozer S, Ulusahin A, Batur S, et al. Outcome measures of interepisode bipolar patients in a Turkish sample. Soc Psychiatry Psychiatr Epidemiol 2002; 37(1): 31–7PubMedCrossRefGoogle Scholar
  66. 66.
    Tsevat J, Keck PE, Hornung RW, et al. Health values of patients with bipolar disorder. Qual Life Res 2000; 9(5): 579–86PubMedCrossRefGoogle Scholar
  67. 67.
    Vojta C, Kinosian B, Glick H, et al. Self-reported quality of life across mood states in bipolar disorder. Compr Psychiatry 2001; 42(3): 190–5PubMedCrossRefGoogle Scholar
  68. 68.
    Ware JE, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34(3): 220–33PubMedCrossRefGoogle Scholar
  69. 69.
    The EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 1990; 16(3): 199–208CrossRefGoogle Scholar
  70. 70.
    Scott J, Paykel E, Morriss R, et al. Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry 2006; 188: 313–20PubMedCrossRefGoogle Scholar
  71. 71.
    Robb JC, Cooke RG, Devins GM, et al. Quality of life and lifestyle disruption in euthymic bipolar disorder. J Psychiatr Res 1997; 31(5): 509–17PubMedCrossRefGoogle Scholar
  72. 72.
    Flanagan JC. A research approach to improving our quality of life. Am Psychol 1978; 33: 138–47CrossRefGoogle Scholar
  73. 73.
    MacQueen GM, Young LT, Robb JC, et al. Effect of number of episodes on wellbeing and functioning of patients with bipolar disorder. Acta Psychiatr Scand 2000; 101(5): 374–81PubMedCrossRefGoogle Scholar
  74. 74.
    Stewart AL, Hays RD, Ware Jr JE. The MOS short-form general health survey: reliability and validity in a patient population. Med Care 1988; 26(7): 724–35PubMedCrossRefGoogle Scholar
  75. 75.
    Sierra P, Livianos L, Rojo L. Quality of life for patients with bipolar disorder: relationship with clinical and demographic variables. Bipolar Disord 2005; 7(2): 159–65PubMedCrossRefGoogle Scholar
  76. 76.
    Endicott J, Spitzer RL. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 1978; 35(7): 837–44PubMedCrossRefGoogle Scholar
  77. 77.
    Cooke RG, Robb JC, Young LT, et al. Well-being and functioning in patients with bipolar disorder assessed using the MOS 20-ITEM short form (SF-20). J Affect Disord 1996; 39(2): 93–7PubMedCrossRefGoogle Scholar
  78. 78.
    Thase ME. Bipolar depression: issues in diagnosis and treatment. Harv Rev Psychiatry 2005; 13(5): 257–71PubMedCrossRefGoogle Scholar
  79. 79.
    Gao K, Calabrese JR. Newer treatment studies for bipolar depression. Bipolar Disord 2005; 7Suppl. 5: 13–23PubMedCrossRefGoogle Scholar
  80. 80.
    Revicki DA, Paramore LC, Sommerville KW, et al. Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes. J Clin Psychiatry 2003; 64(3): 288–94PubMedCrossRefGoogle Scholar
  81. 81.
    Calabrese JR, Keck PE, Macfadden W, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005; 162(7): 1351–60PubMedCrossRefGoogle Scholar
  82. 82.
    Shi L, Namjoshi MA, Swindle R, et al. Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial. Clin Ther 2004; 26(1): 125–34PubMedCrossRefGoogle Scholar
  83. 83.
    Hunt SM, McKenna SP. The QLDS: a scale for the measurement of quality of life in depression. Health Policy 1992; 22(3): 307–19PubMedCrossRefGoogle Scholar
  84. 84.
    Endicott J, Rajagopalan K, Minkwitz M, et al. A randomized, double-blind, placebo-controlled study of quetiapine in the treatment of bipolar I and II depression: improvements in quality of life. Int Clin Psychopharmacol 2007; 22(1): 29–37PubMedCrossRefGoogle Scholar
  85. 85.
    Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382–9PubMedCrossRefGoogle Scholar
  86. 86.
    Katschnig H, Freeman H, Sartorius N, editors. Quality of life in mental disorders. 2nd ed. Chichester: John Wiley and Sons, 1997Google Scholar
  87. 87.
    Kocsis JH, Zisook S, Davidson J, et al. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes. Am J Psychiatry 1997; 154(3): 390–5PubMedGoogle Scholar
  88. 88.
    Miller IW, Keitner GI, Schatzberg AF, et al. The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. J Clin Psychiatry 1998; 59(11): 608–19PubMedCrossRefGoogle Scholar
  89. 89.
    Michalak EE, Yatham LN, Wan DD, et al. Perceived quality of life in patients with bipolar disorder: does group psychoeducation have an impact? Can J Psychiatry 2005; 50(2): 95–100PubMedGoogle Scholar
  90. 90.
    Hlastala SA, Frank E, Mallinger AG, et al. Bipolar depression: an underestimated treatment challenge. Depress Anxiety 1997; 5(2): 73–83PubMedCrossRefGoogle Scholar
  91. 91.
    Altshuler LL, Post RM, Leverich GS, et al. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995; 152(8): 1130–8PubMedGoogle Scholar
  92. 92.
    Goldberg JF, Truman CJ. Antidepressant-induced mania: an overview of current controversies. Bipolar Disord 2003; 5(6): 407–20PubMedCrossRefGoogle Scholar
  93. 93.
    Namjoshi MA, Risser R, Shi L, et al. Quality of life assessment in patients with bipolar disorder treated with olanzapine added to lithium or valproic acid. J Affect Disord 2004; 81(3): 223–9PubMedCrossRefGoogle Scholar
  94. 94.
    Shi L, Namjoshi MA, Zhang F, et al. Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status. Int Clin Psychopharmacol 2002; 17(5): 227–37PubMedCrossRefGoogle Scholar
  95. 95.
    Namjoshi MA, Rajamannar G, Jacobs T, et al. Economic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania: results from a randomized controlled trial. J Affect Disord 2002; 69(1–3): 109–18PubMedCrossRefGoogle Scholar
  96. 96.
    Tohen M, Goldberg JF, Arrillaga AMGP, et al. A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania. Arch Gen Psychiatry 2003; 60(12): 1218–26PubMedCrossRefGoogle Scholar
  97. 97.
    Michalak EE, Yatham LN, Kolesar S, et al. Bipolar disorder and quality of life: a patient-centred perspective. Qual Life Res 2006; 15(1): 25–37PubMedCrossRefGoogle Scholar
  98. 98.
    Michalak EE, Yatham LN, Maxwell V, et al. The impact of bipolar disorder upon work functioning: a qualitative analysis. Bipolar Disord 2006; 9: 126–43CrossRefGoogle Scholar
  99. 99.
    Orley J, Saxena S, Herrman H. Quality of life and mental illness: reflections from the perspective of the WHOQOL. Br J Psychiatry 1998; 172: 291–3PubMedCrossRefGoogle Scholar
  100. 100.
    Vieta E, Gasto C, Otero A, et al. Differential features between bipolar I and bipolar II disorder. Compr Psychiatry 1997; 38(2): 98–101PubMedCrossRefGoogle Scholar
  101. 101.
    Judd LL, Akiskal HS, Schettler PJ, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003; 60(3): 261–9PubMedCrossRefGoogle Scholar
  102. 102.
    Watson S, Gallagher P, Ritchie JC, et al. Hypothalamic pituitary-adrenal axis function in patients with bipolar disorder. Br J Psychiatry 2004; 184: 496–502PubMedCrossRefGoogle Scholar
  103. 103.
    Thompson JM, Gallagher P, Hughes JH, et al. Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br J Psychiatry 2005; 186: 32–40PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2008

Authors and Affiliations

  • Erin E. Michalak
    • 1
    Email author
  • Greg Murray
    • 2
  • Allan H. Young
    • 1
  • Raymond W. Lam
    • 1
  1. 1.Division of Mood Disorders, Department of PsychiatryUniversity of British ColumbiaVancouverCanada
  2. 2.Faculty of Life and Social SciencesSwinburne University of TechnologyMelbourneAustralia

Personalised recommendations